Alere (ALR) volatility flat into Abbott Laboratories (ABT) agreeing to buy at $51 per share rather than previous offer of $56
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Alere (ALR) PT Lowered to $51 at Canaccord Genuity
April 17, 2017 9:27 AM EDTCanaccord Genuity lowered its price target on Alere (NYSE: ALR) to $51.00 (from $52.00) while maintaining a Buy rating. ABT and ALR announced a settlement at $51/share, or ~21% higher than ALR's closing price of $42.31 last Thursday.
Canaccord believes that shareholders would have approved anything at $50+ so... More
Alere (ALR) PT Lowered to $51 at Jefferies Following Announced Revisions to ABT Merger
April 17, 2017 7:17 AM EDTJefferies lowered its price target on Alere (NYSE: ALR) to $51.00 (from $56.00) while maintaining a Hold rating following the company's announced amended the terms of to the merger with ABT.
Key revisions include: 1) $51/share vs. the original $56; 2) timeline extended to September 30 from April 30; and... More
